Drugs that contain Technetium Tc-99m Teboroxime Kit
1. Cardiotec patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6056941 | BRACCO | Kit for the preparation of technetium TC 99m teboroxime myocardial perfusion agent |
Jul, 2019
(4 years ago) | |
Market Authorisation Date: 19 December, 1990
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
CARDIOTEC family patents
